{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:28:55Z","timestamp":1793046535855,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpt.2026.101314","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:11:27Z","timestamp":1775783487000},"page":"101314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Shaakir","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Giap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-318X","authenticated-orcid":false,"given":"Christian","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtiland","family":"Deville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungtaek","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis M.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib1","first-page":"1624","article-title":"Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ijpt.2026.101314_bib2","doi-asserted-by":"crossref","unstructured":"Chikatamarla VA. Risk of metastatic disease using [18F]PSMA-1007 PET\/CT for primary prostate cancer staging. Published Online September 2, 2021. doi:10.21203\/RS.3.RS-796934\/V1.","DOI":"10.21203\/rs.3.rs-796934\/v1"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2019.10.008","article-title":"Local failure and survival after definitive radiotherapy for aggressive prostate cancer: an individual patient-level meta-analysis of six randomized trials","volume":"77","author":"Kishan","year":"2020","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib4","first-page":"701","article-title":"Underutilization of local salvage therapy after radiation therapy for prostate cancer","volume":"32","author":"Tran","year":"2014","journal-title":"Urol\u00a0Oncol\u00a0Semin\u00a0Ori\u00a0Invest"},{"key":"10.1016\/j.ijpt.2026.101314_bib5","unstructured":"Marcus DM, Canter DJ, Jani AB, et al. Salvage therapy for locally recurrent prostate cancer after radiation. Can J Urol. 2012;19(6):6534\u20136541. Accessed November 5, 2019. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23228288."},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00345-012-0928-8","article-title":"Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review","volume":"31","author":"Peters","year":"2013","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2016.05.024","article-title":"Reirradiation of prostate cancer local failures after previous curative radiation therapy: long-term outcome and tolerance","volume":"96","author":"Zilli","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101314_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102176","article-title":"Outcomes and toxicities of re-irradiation for prostate cancer: a systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","volume":"95","author":"Munoz","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ijrobp.2009.06.061","article-title":"Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer","volume":"77","author":"Burri","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.brachy.2015.01.002","article-title":"Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: association between dose and late toxicity","volume":"14","author":"Rose","year":"2015","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2013.01.027","article-title":"Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes","volume":"86","author":"Chen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib13","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/j.prro.2022.05.018","article-title":"A prospective study of magnetic resonance imaging-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: updated results of 30 patients","volume":"12","author":"Corkum","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2018.09.039","article-title":"A prospective phase 2 trial of transperineal ultrasound-guided brachytherapy for locally recurrent prostate cancer after external beam radiation therapy (NRG oncology\/RTOG-0526)","volume":"103","author":"Crook","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2013.08.019","article-title":"Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials","volume":"87","author":"King","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib16","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/j.prro.2015.04.009","article-title":"High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment","volume":"5","author":"Fuller","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101314_bib17","doi-asserted-by":"crossref","unstructured":"Ekanger C, Helle SI, Reis\u00c6ter L, et al. Salvage reirradiation for locally recurrent prostate cancer: results from a prospective study with 7.2 years of follow-up. Published online April 23, 2024. doi:10.1200\/JCO.23.01391.","DOI":"10.1200\/JCO.23.01391"},{"key":"10.1016\/j.ijpt.2026.101314_bib18","article-title":"Salvage stereotactic body radiation therapy for local prostate cancer recurrence after radiation therapy: a retrospective multicenter study of the GETUG","author":"Pasquier","year":"2019","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol*Biol*Phys"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ijrobp.2010.11.031","article-title":"Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer","volume":"82","author":"Jereczek-Fossa","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1052","key":"10.1016\/j.ijpt.2026.101314_bib20","article-title":"Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer","volume":"88","author":"Zerini","year":"2015","journal-title":"Br\u00a0J\u00a0Radiol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib21","first-page":"95","article-title":"Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center","volume":"12","author":"Leroy","year":"2017","journal-title":"Radiat\u00a0Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euo.2023.01.009","article-title":"The safety and efficacy of salvage stereotactic radiation therapy in patients with intraprostatic tumor recurrence after previous external radiation therapy: phase 1 results from the GETUG-AFU 31 study","volume":"6","author":"Pasquier","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2020.07.014","article-title":"Interim results of a prospective prostate-specific membrane antigen-directed focal stereotactic reirradiation trial for locally recurrent prostate cancer","volume":"108","author":"Bergamin","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2021.10.138","article-title":"Salvage low dose rate prostate brachytherapy: clinical outcomes of a phase II trial for local recurrence after external beam radiotherapy (NRG oncology\/0526)","volume":"112","author":"Crook","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101314_bib25","unstructured":"Schaeffer EM, \u03c9 C, An Y,\u00a0et al. NCCN guidelines version 4.2023 prostate cancer. Published online 2023. Accessed September 16, 2023. https:\/\/www.nccn.org\/home\/."},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2021.06.010","article-title":"OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer","volume":"80","author":"Supiot","year":"2021","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.ijpt.2026.101314_bib27","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s00345-018-2322-7","article-title":"Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer","volume":"37","author":"Fodor","year":"2019","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtho.2016.10.018","article-title":"Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung cancer","volume":"12","author":"Chao","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijrobp.2016.02.036","article-title":"Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes","volume":"95","author":"Romesser","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2017.08.005","article-title":"Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation","volume":"125","author":"Verma","year":"2017","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.02.045","article-title":"Dose escalation for prostate adenocarcinoma: a long-term update on the outcomes of a phase 3, single institution randomized clinical trial","volume":"104","author":"Pasalic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib32","first-page":"6","article-title":"New insights in the relative radiobiological effectiveness of proton irradiation","volume":"13","author":"Ilicic","year":"2018","journal-title":"Radiat\u00a0Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib33","doi-asserted-by":"crossref","first-page":"e2250607","DOI":"10.1001\/jamanetworkopen.2022.50607","article-title":"Evaluation of proton therapy reirradiation for patients with recurrent head and neck squamous cell carcinoma","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib34","article-title":"Reirradiation with proton therapy for recurrent malignancies of the esophagus and gastroesophageal junction: results of the proton collaborative group multi-institutional prospective registry trial","volume":"9","author":"Hotca","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"6-7","key":"10.1016\/j.ijpt.2026.101314_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.canrad.2021.06.024","article-title":"Role of proton therapy in reirradiation and in the treatment of sarcomas","volume":"25","author":"Doyen","year":"2021","journal-title":"Cancer Radiother"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib36","doi-asserted-by":"crossref","first-page":"100710","DOI":"10.1016\/j.adro.2021.100710","article-title":"Proton reirradiation for locoregionally recurrent breast cancer","volume":"6","author":"LaRiviere","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semradonc.2020.02.007","article-title":"Proton reirradiation: expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies","volume":"30","author":"Simone","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101314_bib38","unstructured":"PTCOG 61 Research highlight: benefits of proton reirradiation. Accessed May 11, 2024. https:\/\/www.nyproton.com\/ptcog-61-research-benefits-of-proton-reirradiation\/."},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2023.12.041","article-title":"Temporal evolution and diagnostic diversification of patients receiving proton therapy in the United States: a ten-year trend analysis (2012 to 2021) from the national association for proton therapy","volume":"119","author":"Hartsell","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101314_bib40","unstructured":"Model Policies - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO). Accessed May 12, 2024. https:\/\/www.astro.org\/daily-practice\/reimbursement\/model-policies."},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib41","article-title":"Reirradiation for rectal cancer using pencil beam scanning proton therapy: a single institutional experience","volume":"6","author":"Koroulakis","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101314_bib42","first-page":"59","article-title":"Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies","volume":"19","author":"Moningi","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.radonc.2017.06.024","article-title":"A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma","volume":"124","author":"Guttmann","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2026.101314_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.930393","article-title":"Proton induced DNA double strand breaks at the Bragg peak: evidence of enhanced LET effect","volume":"12","author":"Frame","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib45","first-page":"86","article-title":"Variations in the processing of DNA double-strand breaks along 60-MeV therapeutic proton beams","volume":"95","author":"Chaudhary","year":"2016","journal-title":"Int\u00a0J\u00a0Radiat Oncol*Biol*Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib46","first-page":"1","article-title":"68Ga-PSMA PET\/CT in early relapsed prostate cancer patients after radical therapy","volume":"12","author":"Haidar","year":"2022","journal-title":"Sci\u00a0Rep\u00a02022"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rcl.2017.10.008","article-title":"Prostate MR imaging for post-treatment evaluation and recurrence","volume":"56","author":"Gaur","year":"2018","journal-title":"Radiol Clin North Am"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib48","first-page":"786","article-title":"Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology","volume":"60","author":"Hope","year":"2019","journal-title":"J\u00a0Nucl\u00a0Med"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib49","article-title":"The importance of multi-parametric MRI, PET\/CT, and biopsy for identifying and delineating the extent of locally radiorecurrent prostate cancer: a multi-institutional analysis of the F-SHARP clinical trial","volume":"117","author":"Ross","year":"2023","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol*Biol*Phys"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib50","article-title":"Dose-escalated preoperative proton therapy for retroperitoneal sarcomas: initial outcomes of a new treatment paradigm","volume":"9","author":"Yarlagadda","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101314_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1241711","article-title":"Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study","volume":"13","author":"Ong","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.ijpt.2026.101314_bib54","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2017.75.5371","article-title":"Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer","volume":"36","author":"Pan","year":"2018","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ijpt.2026.101314_bib55","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2016.01.055","article-title":"First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer","volume":"95","author":"Veiga","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.radonc.2015.07.028","article-title":"Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy","volume":"117","author":"Andrzejewski","year":"2015","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2019.11.402","article-title":"Standard and hypofractionated dose escalation to intraprostatic tumor nodules in localized prostate cancer: efficacy and toxicity in the DELINEATE trial","volume":"106","author":"Murray","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ijpt.2026.101314_bib59","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1118\/1.2982242","article-title":"Dosimetric uncertainty in prostate cancer proton radiotherapy","volume":"35","author":"Lin","year":"2008","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib60","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2010.08.006","article-title":"Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer","volume":"80","author":"Trofimov","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib61","article-title":"Dosimetric uncertainties in dominant intraprostatic lesion simultaneous boost using intensity modulated proton therapy","volume":"7","author":"Zhou","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101314_bib62","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1002\/mp.13122","article-title":"Development of deep neural network for individualized hepatobiliary toxicity prediction after liver SBRT","volume":"45","author":"Ibragimov","year":"2018","journal-title":"Med Phys"},{"issue":"17","key":"10.1016\/j.ijpt.2026.101314_bib63","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1088\/0031-9155\/54\/17\/005","article-title":"Using dose-surface maps to predict radiation-induced rectal bleeding: a neural network approach","volume":"54","author":"Buettner","year":"2009","journal-title":"Phys Med Biol"},{"issue":"11","key":"10.1016\/j.ijpt.2026.101314_bib64","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1088\/1361-6560\/aa5c12","article-title":"Near real-time automated dose restoration in IMPT to compensate for daily tissue density variations in prostate cancer","volume":"62","author":"Jagt","year":"2017","journal-title":"Phys Med Biol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2019.10.014","article-title":"Retreatment for local recurrence of prostatic carcinoma after prior therapeutic irradiation: efficacy and toxicity of HDR-like SBRT","volume":"106","author":"Fuller","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101314_bib66","unstructured":"Study Details | Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors | ClinicalTrials.gov. Accessed May 19, 2024. https:\/\/clinicaltrials.gov\/study\/NCT05313191."},{"key":"10.1016\/j.ijpt.2026.101314_bib67","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1748-717X-9-96","article-title":"Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial","volume":"9","author":"Uhl","year":"2014","journal-title":"Radiat Oncol"},{"issue":"6_suppl","key":"10.1016\/j.ijpt.2026.101314_bib68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2022.40.6_suppl.247","article-title":"Impact of rectal spacer on toxicity reduction in men treated with proton versus photon therapy","volume":"40","author":"Dhere","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib69","first-page":"1","article-title":"Increasing rectum\u2013prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer","volume":"13","author":"Narukawa","year":"2023","journal-title":"Sci\u00a0Rep\u00a02023"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib70","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaoncol.2022.7592","article-title":"Hyaluronic acid spacer for hypofractionated prostate radiation therapy: a randomized clinical trial","volume":"9","author":"Mariados","year":"2023","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib71","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jbm.b.31467","article-title":"Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer","volume":"91","author":"Levy","year":"2009","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.ijpt.2026.101314_bib72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1748-717X-8-96","article-title":"Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study","volume":"8","author":"Gez","year":"2013","journal-title":"Radiat Oncol"},{"issue":"8","key":"10.1016\/j.ijpt.2026.101314_bib73","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.canrad.2020.03.009","article-title":"Hyaluronic acid spacer in focal prostate reirradiation: a single centre experience","volume":"24","author":"Ozyigit","year":"2020","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib74","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.brachy.2014.05.001","article-title":"Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: initial experience and short-term results","volume":"13","author":"Mahal","year":"2014","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brachy.2012.03.005","article-title":"High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature","volume":"12","author":"Nguyen","year":"2013","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO Guideline, Part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib77","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","article-title":"A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling","volume":"66","author":"Klein","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib78","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.mayocp.2013.12.001","article-title":"Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model","volume":"89","author":"Tollefson","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib79","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.juro.2014.02.003","article-title":"Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy","volume":"192","author":"Bishoff","year":"2014","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib80","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.eururo.2019.05.013","article-title":"The state of the science on prostate cancer biomarkers: the San Francisco consensus statement","volume":"76","author":"Cooperberg","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bju.16150","article-title":"F-SHARP: a phase I\/II trial of focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer","volume":"133","author":"Solanki","year":"2024","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib82","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib83","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0360-3016(91)90068-F","article-title":"Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate","volume":"20","author":"Kaplan","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib84","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.brachy.2016.08.004","article-title":"Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy","volume":"15","author":"Rutenberg","year":"2016","journal-title":"Brachytherapy"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101314_bib85","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00432-020-03297-5","article-title":"PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","volume":"146","author":"Zerini","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijpt.2026.101314_bib86","unstructured":"2019 ABS Annual Meeting: Agenda. Accessed July 6, 2024. https:\/\/www.americanbrachytherapy.org\/meetings-events\/annual-2019\/agenda\/agenda\/."},{"key":"10.1016\/j.ijpt.2026.101314_bib87","unstructured":"ESTRO - Programme. Accessed July 6, 2024. https:\/\/www.estro.org\/Congresses\/ESTRO-2024\/programme?p=21."},{"key":"10.1016\/j.ijpt.2026.101314_bib88","unstructured":"Program at Glance | 9th PTCOG NA Annual Conference. Accessed July 5, 2024.\u00a0https:\/\/www.ptcog-na.org\/ptcog-na-l-ninth-annual-conference\/program-at-glance-new."},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib89","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2017.08.005","article-title":"Topography of prostate cancer recurrence after radiation therapy: a detailed mapping study of salvage radical prostatectomy specimens","volume":"73","author":"Takeda","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijpt.2026.101314_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1241711","article-title":"Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study","volume":"13","author":"Ong","year":"2023","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/srao.2000.6593","article-title":"Tissue tolerance to reirradiation","volume":"10","author":"Nieder","year":"2000","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib92","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2019.07.009","article-title":"Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy","volume":"76","author":"De Bleser","year":"2019","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib93","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(25)00197-4","article-title":"Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V\u2013STORM): a phase 2, open-label, randomised controlled trial","volume":"26","author":"Ost","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib94","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijrobp.2015.07.2205","article-title":"Initial report of pencil beam scanning proton therapy for posthysterectomy patients with gynecologic cancer","volume":"95","author":"Lin","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib95","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/j.ijrobp.2011.07.012","article-title":"Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies","volume":"82","author":"Milby","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib96","doi-asserted-by":"crossref","first-page":"101191","DOI":"10.1016\/j.adro.2023.101191","article-title":"Clinical outcomes of intensity modulated proton therapy reirradiation for gynecologic malignancies","volume":"8","author":"Pollock","year":"2023","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib97","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ijpt.2026.101314_bib98","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/02841860701317873","article-title":"Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer","volume":"46","author":"Gunnlaugsson","year":"2007","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101314_bib99","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2006.05.005","article-title":"Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning","volume":"66","author":"Tho","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101314_bib100","first-page":"130","article-title":"PEARLS - A multicentre phase II\/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and\/or para-aortic lymph nodes at presentation","volume":"37","author":"Murray","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib101","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.prro.2021.03.006","article-title":"Long-term outcomes of dose-escalated pelvic lymph node intensity-modulated radiation therapy (IMRT) with a simultaneous hypofractionated boost to the prostate for very high-risk adenocarcinoma of the prostate: a prospective phase ii clinical trial","volume":"11","author":"Hall","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101314_bib102","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.wneu.2018.05.209","article-title":"Comparison of the effectiveness of radiotherapy with photons and particles for chordoma after surgery: a meta-analysis","volume":"117","author":"Zhou","year":"2018","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101314_bib103","doi-asserted-by":"crossref","DOI":"10.3171\/2024.2.FOCUS23927","article-title":"Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection","volume":"56","author":"Ghaith","year":"2024","journal-title":"Neurosurg Focus"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101314_bib104","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijrobp.2022.05.040","article-title":"Para-Aortic radiation therapy for oligorecurrent prostate cancer","volume":"114","author":"Rich","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101314_bib105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.euo.2023.03.005","article-title":"Salvage stereotactic reirradiation for local recurrence in the prostatic bed after prostatectomy: a retrospective multicenter study","volume":"6","author":"Archer","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101314_bib106","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7785\/tcrt.2012.500261","article-title":"Re-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region","volume":"11","author":"Abusaris","year":"2012","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101314_bib107","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.clon.2020.06.009","article-title":"Stereotactic pelvic reirradiation for locoregional cancer relapse","volume":"33","author":"Kinj","year":"2021","journal-title":"Clin Oncol"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S233151802600017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S233151802600017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:53:18Z","timestamp":1780955598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S233151802600017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":107,"alternative-id":["S233151802600017X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101314","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101314"}}